Unlocking the secrets of a critical schistosomiasis drug — ScienceDaily

Independent teams from Texas Biomedical Research Institute and the Medical College of Wisconsin have published two papers in Science Translational Medicine identifying how the only approved drug to treat schistosomiasis, a widespread parasitic worm infection, works on the molecular level.

Click here to view the original article.